Enterocytes exist in close association with tissue macrophages, whose activation during inflammatory processes leads to the release of nitric oxide. Repair from mucosal injury requires the migration of enterocytes into the mucosal defect, a process that requires connexin43-mediated gap junction communication between adjacent enterocytes. Enterocyte migration is inhibited during inflammatory conditions including necrotizing enterocolitis, in part through impaired gap junction communication. We now hypothesize that activated macrophages inhibit gap junctions of adjacent enterocytes, and sought to determine whether nitric oxide release from macrophages was involved. Using a co-culture system of enterocytes and macrophages, we now demonstrate that "activation" of macrophages with lipopolysaccharide and interferon reduces the phosphorylation of connexin43 in adjacent enterocytes, an event known to inhibit gap junction communication. The effects of macrophages on enterocyte gap junctions could be reversed by treatment of macrophages with the iNOS inhibitor L-Nil and by incubation with macrophages from iNOS-/- mice, implicating NO in the process. Activated macrophages also caused a NO-dependent redistribution of connexin43 in adjacent enterocytes from the cell surface to an intracellular location, further suggesting NO release may inhibit gap junction function. Treatment of enterocytes with the NO donor SNAP markedly inhibited gap junction communication as determined using single cell microinjection of the gap junction tracer Lucifer yellow. Strikingly, activated macrophages inhibited enterocyte migration into a scraped wound, which was reversed by L-Nil pretreatment. These results implicate enterocyte gap junctions as a target of the NO-mediated effects of macrophages during intestinal inflammation, particularly where enterocyte migration is impaired.